Sabado 30 Septiembre :
424P Clinical and pharmacokinetic phase I combination study of Trabectedin (T) and Carboplatin (C) in patients with advanced solid tumors Ramon Salazar .
755P Phase II clinical trial of Kahalalide F (KF) as a second line therapy in patients (pts) with advanced non-small cell lung cancer (NSCLC). Mariano Provencio .
1114P Pharmacokinetic (PK) and clinical phase II study of weekly intravenous Kahalalide F (KF) as first-line therapy in patients (pts) with hepatocarcinoma (HC). Fernando Rivera .
Domingo 1 Octubre :
448P Plitidepsin in patients with advanced renal cancer (RCC): Results of an exploratory phase II trial Miguel Climent,
449P Plitidepsin 5mg/m2 (arm A) versus 7 mg/m2 plus L-carnitine (arm B): Phase II randomised trial in advanced renal and colorectal cancer Josep Tabernero .
Oral :
14:45 Innovative treatment approaches in colon cancer Josep Tabernero, ES .
Martes 2 Octubre :
Final results of a phase II trial of 3-hr infusion trabectedin in patients with recurrent sarcomas Palma Di Leo .
518P Phase II clinical trial of Kahalalide F (KF) as a 1-hour infusion every week in patients (pts) with advanced malignant melanoma (AMM) Luis Paz-Ares .
354P Plitidepsin in patients with advanced colorectal cancer (CRC): Results of an exploratory phase II trial Josep Tabernero .